XORTX Announces Results of Annual and Special Meeting of Shareholders

6 days ago

CALGARY, Alberta, Sept. 13, 2024 ( GLOBE NEWSWIRE ) -- XORTX Therapeutics Inc. ( "XORTX" or the "Company" ) ( NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU ) , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to ...

Ticker	Sentiment	Impact
XRTX	Somewhat Bullish	15 %